Treatment with α-santalol showed a sharp decrease in the phosphorylation of mTOR and p70S6K, and its upstream kinase, AKT, suggesting that α-santalol suppresses tumor angiogenesis by inhibiting VEGFR2 and blocking its multiple downstream signaling components. The gene discussed is MTOR; the disease is neoplasm.